PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsBuprenorphine hydrochloride
Buprenorphine hydrochloride
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
772 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Opioid-related disordersD009293EFO_0005611F11611326768198498
Substance-related disordersD019966EFO_0003890F131623111458117
Chronic painD059350810791747
PainD010146EFO_0003843R528410101142
Heroin dependenceD006556EFO_0004240415104534
Hiv infectionsD015658EFO_0000764B2026371430
DepressionD003863F33.94572924
Healthy volunteers/patients162624
Addictive behaviorD016739EFO_000434765141123
OsteoarthritisD010003EFO_0002506M15-M191137223
Show 59 more
Indications Phases 3
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Post-traumatic stress disordersD013313EFO_0001358F43.1369
AlcoholismD000437EFO_0003829F10.1268
Traumatic stress disordersD040921224
MucositisD052016EFO_1001898122
Recreational drug useD000084783112
CravingD066249112
Dental pinsD00377222
ToothacheD014098K08.8922
Cigarette smokingD000073865112
Drug interactionsD004347111
Show 21 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Anxiety disordersD001008EFO_0006788F41.1167
RecurrenceD012008224
PharmacokineticsD01059933
Psychological well-beingD000092862123
Sleep wake disordersD012893G47123
Respiratory insufficiencyD012131J96.9112
Tissue adhesionsD00026722
Renal insufficiencyD051437N1911
Musculoskeletal painD05935211
HepacivirusD01617411
Show 5 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Mental disordersD001523EFO_0000677F91.944
Medication adherenceD055118EFO_000634444
Harm reductionD04026144
Treatment adherence and complianceD00007482233
AnxietyD001007EFO_0005230F41.133
Risk reduction behaviorD04024222
Patient acceptance of health careD01034222
Cardiovascular diseasesD002318EFO_0000319I9822
Immunologic deficiency syndromesD007153D84.922
HyperalgesiaD00693022
Show 37 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
11,976 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use